Comparing blood glucose management methods in diabetic patients after pancreas surgery
Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy : A Randomized Controlled Open Labeled Trial
NA · Seoul National University Hospital · NCT05149625
This study is testing whether continuous glucose monitoring or traditional blood sugar checks work better and make diabetic patients happier after they've had pancreas surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 172 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Seoul National University Hospital (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT05149625 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness and patient satisfaction of continuous glucose monitoring versus traditional self-blood glucose measurement in diabetic patients who have undergone pancreatectomy. Patients will be randomly assigned to one of the two monitoring methods after a glucose tolerance test conducted one week post-surgery. Over a three-month period, outcomes such as HbA1c levels, hypoglycemic events, and overall satisfaction will be evaluated to determine which method provides better management of blood glucose levels.
Who should consider this trial
Good fit: Ideal candidates are adults over 19 years old with a history of diabetes who have undergone subtotal or total pancreatectomy.
Not a fit: Patients with prior experience using continuous glucose monitoring devices or those with serious systemic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved blood glucose management strategies for diabetic patients post-pancreatectomy.
How similar studies have performed: Previous studies have shown promising results with continuous glucose monitoring in diabetic management, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 19 years of age * Preoperative diabetes history * Patients who underwent subtotal or total pancreatectomy * Patients who were diagnosed with diabetes mellitus in the evaluation of endocrine function test on the 7th day after pancreaticoduodenectomy, central pancreatectomy, or distal pancreatectomy Exclusion Criteria: * Patients who have used continuous blood glucose measurement device more than once before. * Elderly patients who are not accustomed to using the smartphone applications * Serious systemic diseases that can affect diabetes (chronic kidney disease, heart failure, decompensated liver cirrhosis, etc.) * Steroid user during the study period * Major medical or psychiatric condition that will affect response to treatment
Where this trial is running
Seoul
- Department of Surgery, Seoul National University College of Medicine — Seoul, South Korea (RECRUITING)
Study contacts
- Principal investigator: Jin-Young Jang, Dr — Seoul National University Hospital
- Study coordinator: Jin-Young Jang, Dr
- Email: jangjy4@gmail.com
- Phone: +82-02-2072-2194
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus